Key result
Inflammatory bowel disease linked to markedly higher serum thrombopoietin levels versus healthy controls.
Why the study?
Elevated platelet count is a recognized marker of IBD activity, but the relationship between thrombopoietin levels and IBD clinical characteristics was unclear.
Are serum levels of endogenous Thrombopoietin (TPO) elevated in patients with inflammatory bowel disease compared to healthy controls?
Case-Control (n=145)
Are serum levels of endogenous Thrombopoietin (TPO) elevated in patients with inflammatory bowel disease compared to healthy controls?
Thrombopoietin levels are significantly elevated in patients with inflammatory bowel disease regardless of disease activity or platelet counts, suggesting a potential role in the procoagulant state of IBD.
Answers are grounded in this paper and cite their sources.
Elevated TPO may contribute to IBD procoagulant state; hypothesis-generating for causality and therapeutic targeting.
OBJECTIVES: Elevated platelet count is a well recognized marker of inflammatory bowel disease (IBD) activity. Thrombopoietin (TPO) is a critical cytokine in the physiological regulation of thrombopoiesis. The aim of this study was to investigate the serum levels of endogenous TPO in patients with IBD, the relationship between platelet counts and TPO levels, and the correlation of TPO with the clinical characteristics of the patients. METHODS: TPO levels in 40 patients with Crohn's disease (CD), 63 patients with ulcerative colitis (UC), and in 42 healthy blood donors were assessed by ELISA. Platelet and white blood cell counts as well as C-reactive protein, and erythrocyte sedimentation rate were measured. RESULTS: TPO levels were significantly elevated in patients with CD (mean 124.3 +/- SD 58.0 pg/ml, p < 0.0001) and in patients with UC (mean 152.2 +/- SD 142.3 pg/ml, p < 0.0001), compared to controls (mean 53.4 +/- SD 45.7 pg/ml). TPO levels remained significantly elevated in remission (mean 144.7 +/- SD 131.1 pg/ml, p < 0.0001 compared to controls). Platelets were significantly elevated only in active CD, being normal in inactive disease as well as in all patients with UC. There was no significant correlation between TPO levels and various clinical characteristics of patients with IBD. No significant correlation was found between TPO levels and either platelet counts or white blood cell counts, erythrocyte sedimentation rate, and C-reactive protein. CONCLUSIONS: TPO levels are increased in IBD, irrespective of disease activity, platelet counts, and clinical characteristics of the patients. These observations indicate that TPO, apart from being a platelet producer, might have additional functions, probably related to the procoagulant state of IBD.
No takes yet. Share an insight, caveat, or question.
Kapsoritakis et al. (2000) conducted a case-control in Inflammatory Bowel Disease (n=145). Inflammatory Bowel Disease vs. Healthy blood donors was evaluated on Serum levels of endogenous thrombopoietin (TPO) (p=< 0.0001). Inflammatory bowel disease was associated with elevated serum thrombopoietin levels in Crohn's disease and ulcerative colitis vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: